Click
here for printer-friendly version
* Net income was $1.17 per share, including net realized investment losses of $0.01 per share, exceeding previous expectations * With stable benefit expense ratios, pre-tax margin increased to 8.5 percent * The Company repurchased 23.3 million shares of its common stock during the second quarter for $1.7 billion * Full year 2006 earnings guidance raised to $4.74 per share, including net realized investment losses of $0.02 per shareINDIANAPOLIS, July 26, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- WellPoint, Inc.
(NYSE: WLP) today announced that second quarter 2006 net income was $751.2
million, or $1.17 per share, including costs of $0.05 per share for the impact
of expensing stock options in accordance with FAS 123R and net realized
investment losses of $0.01 per share. Net income for the second quarter of
2005 was $559.4 million, or $0.90 per share, which included expenses of $0.10
per share related to an agreement resolving two national multi-district
lawsuits with physicians.
"We are very pleased with our strong second quarter results that reinforce
the very high expectations we set for ourselves at the beginning of the year,"
said Larry C. Glasscock, chairman, president and chief executive officer of
WellPoint, Inc. "From a financial perspective, earnings per share growth was
very strong, administrative costs as a percentage of revenue continued to
improve and our medical expense ratio declined compared to the first quarter.
We also introduced several new products and services that will further engage
consumers in managing their health care, and offer more benefit options to our
diverse customer base. During the second half of 2006, we expect continued
membership growth, but not at the expense of profitability."
"We have used the excellent cash flow in the first six months of 2006 to
improve equity returns," said David C. Colby, executive vice president and
chief financial officer of WellPoint, Inc. "During the second quarter, we
repurchased 23.3 million shares of our common stock for $1.7 billion. With
Board approval of an additional $1.0 billion in share repurchase authorization
during the quarter, we repurchased a total of 48.0 million shares for $3.6
billion through the first half of 2006. As expected, our year-to-date
operating cash flow reached $2.0 billion and we continue to expect that full
year 2006 operating cash flow will exceed $4.0 billion."
"With this second quarter earnings release, we are providing a
Reconciliation of Medical Claims Payable," added Colby. "The magnitude of
positive prior period development continues to reflect the conservative and
consistent nature of our reserving processes."
COMPARABLE BASIS INFORMATION
On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc. For
accounting purposes, the transaction was assumed to have closed on December
31, 2005. Accordingly, operations of the former WellChoice, Inc. are included
in reported financial results for 2006. However, operations of the former
WellChoice, Inc. are not included in reported financial results for 2005.
Unless otherwise indicated, the analysis in this press release compares
reported financial results and does not adjust results for the effects of this
acquisition. In certain areas, we have included "comparable basis" analyses
that we believe provide more meaningful comparisons between periods, due to
the inclusion of operations of the former WellChoice, Inc. in the comparable
historical results. The "comparable basis" information is not calculated in
accordance with U.S. generally accepted accounting principles ("GAAP") and is
not intended to represent or be indicative of the results that WellPoint, Inc.
would have reported had the acquisition been completed as of the dates
presented, and should not be taken as representative or indicative of our
future results. The methodologies for calculating the comparable basis
information are either described within the text of the press release, or in
the tables at the end of the press release where such comparable basis
information is reconciled to WellPoint, Inc.'s reported GAAP financial
results.
CONSOLIDATED HIGHLIGHTS
Membership: Medical enrollment totaled 34.2 million members at June 30,
2006, an increase of more than 5.3 million members from 28.8 million at June
30, 2005, including approximately 4.8 million members acquired through the
WellChoice transaction.
On a comparable basis, enrollment increased by 616,000 members since June
30, 2005. Each of the Company's geographic regions increased by more than
100,000 members, as consumers continue to be attracted to WellPoint's
expansive, cost-effective provider networks, superior customer service and
leading health improvement and wellness programs. From a customer segment
perspective, the increase in membership was driven by growth of 726,000
members in the National business and 102,000 members in State Sponsored
operations. Growth was also realized in the Individual and Small Group
("ISG") and Senior businesses, while Large Group enrollment declined primarily
due to the previously-announced losses of 377,000 members in the states of
Georgia and Kentucky accounts.
Medical enrollment remained relatively flat during the second quarter of
2006. Fully-insured enrollment increased by 22,000 members despite in-group
enrollment declines in the automotive industry. Self-funded enrollment
declined sequentially due to the discontinuation of a rental network in Texas,
resulting in the loss of 67,000 members.
Medicare Part D enrollment exceeded 1.5 million members as of June 30,
2006, as the Company added approximately 230,000 members during the second
quarter.
Operating Revenue: Operating revenue exceeded $13.9 billion in the second
quarter of 2006, an increase of 26.9 percent from approximately $11.0 billion
in the prior year quarter.
On a comparable basis, second quarter 2006 operating revenue increased by
$1.3 billion, or 10.5 percent, versus $12.6 billion in the prior year period.
The increase resulted primarily from disciplined pricing, the addition of the
New York state prescription drug contract and enrollment in the Company's
Medicare Part D products.
Benefit Expense Ratio: The benefit expense ratio was 81.2 percent in the
second quarter of 2006, a 50 basis point increase compared with 80.7 percent
in the second quarter of 2005.
On a comparable basis, the benefit expense ratio declined by 10 basis
points, from 81.3 percent in the second quarter of 2005. The overall 10 basis
point decline resulted from a 30 basis point decline due to the non-recurrence
of expenses related to the multi-district settlement agreement and a 20 basis
point increase due primarily to year-over-year mix of business changes,
including Medicare Part D and the New York state prescription drug contract.
The benefit expense ratio declined by 10 basis points sequentially, from
81.3 percent in the first quarter of 2006. Second quarter results included an
improved benefit expense ratio for the Company's Medicare Part D products.
Premium and Cost Trends: Trends include Large Group and ISG fully-insured
businesses.
For the rolling 12-month period ended June 30, 2006, the primary drivers
of medical trend were outpatient and inpatient costs. Commercial premium
yield for the same period exceeded total cost trend, where total cost trend
included medical costs and selling, general and administrative ("SG&A")
expense, resulting in an increase in underwriting margin. The Company
continues to expect that full year 2006 medical cost trend will be less than
8.0 percent.
SG&A Expense Ratio: The SG&A expense ratio was 15.7 percent in the second
quarter of 2006, a decrease of 100 basis points from 16.7 percent in the
second quarter of 2005.
On a comparable basis, the SG&A expense ratio declined by 90 basis points,
compared with 16.6 percent in the second quarter of 2005. The ratio improved
year-over-year as the Company continued to control spending, spread
administrative expenses across a growing revenue base and realize integration
synergies and efficiencies.
The current quarter included costs for stock option expensing, which added
approximately 40 basis points to the SG&A expense ratio. The second quarter
2005 ratio was unfavorably impacted by approximately 50 basis points as a
result of the multi-district settlement agreement.
The SG&A expense ratio declined by 30 basis points compared with 16.0
percent in the first quarter of 2006, reflecting continued leveraging of
overhead costs across a growing revenue base.
Operating Cash Flow: For the first six months of 2006, operating cash flow
totaled $2.0 billion, or 1.3 times net income. Operating cash flow totaled
$201.0 million in the second quarter, which was lower than the first quarter
level due to two estimated income tax payments totaling $756.0 million that
were made during the second quarter and the timing of CMS payments received
during the first quarter.
Days in Claims Payable: Days in claims payable as of June 30, 2006, was
44.8 days, a decrease of 0.6 days from 45.4 days as of March 31, 2006. This
decrease was primarily due to a further reduction in the length of time
between the date of service and claim payment, and the timing of payments in
the PBM operation.
Share Repurchase Program: During the second quarter 2006, the Company
repurchased 23.3 million shares of its common stock for $1.7 billion. The
Board of Directors increased the share repurchase authorization by $1.0
billion on May 16, 2006, to $4.0 billion in 2006. As of June 30, 2006, there
was $399.6 million available under the Board's current repurchase
authorization. Based on the current stock price and strong year-to-date
financial results, the Company intends to utilize this remaining authorization
during the third quarter of 2006, subject to market conditions. At June 30,
2006, cash and investments held at the parent company totaled $884.1 million.
REPORTABLE SEGMENTS
WellPoint, Inc. has three reportable segments: Health Care, Specialty and
Other. Operating revenue and operating gain are the key measures used by
management to evaluate performance in each segment.
WellPoint, Inc.
Reportable Segment Highlights
(Unaudited)
($ In Millions) Three Months Ended June 30
2006 2005 Change
Operating Revenue
Health Care $13,391.2 $10,474.9 27.8%
Specialty 880.4 752.6 17.0%
Other:
External Customers 114.9 84.3 36.3%
Intercompany Eliminations (444.2) (325.4) (36.5%)
Total Other (329.3) (241.1) (36.6%)
Total Operating Revenue 13,942.3 10,986.4 26.9%
Operating Gain (Loss)
Health Care $1,060.6 $777.2 36.5%
Specialty 138.1 99.0 39.5%
Other (26.6) (23.4) (13.7%)
($ In Millions) Six Months Ended June 30
2006 2005 Change
Operating Revenue
Health Care $26,449.1 $20,758.0 27.4%
Specialty 1,734.6 1,503.5 15.4%
Other:
External Customers 231.3 172.4 34.2%
Intercompany Eliminations (858.0) (642.1) (33.6%)
Total Other (626.7) (469.7) (33.4%)
Total Operating Revenue 27,557.0 21,791.8 26.5%
Operating Gain (Loss)
Health Care $2,096.5 $1,633.9 28.3%
Specialty 251.7 193.4 30.1%
Other (40.6) (70.9) 42.7%
Health Care: Operating gain for the Health Care segment was approximately
$1.1 billion in the second quarter of 2006, an increase of 36.5 percent,
compared with $777.2 million in the second quarter of 2005.
On a comparable basis, second quarter 2006 operating gain increased by
$185.7 million, or 21.2 percent, versus $874.9 million in the prior year
quarter. Performance in the Health Care segment improved year-over-year due
to enrollment growth, disciplined underwriting and a focus on expense control,
including benefits realized through integration initiatives. Operating gain
in the second quarter 2006 included costs of $51.3 million for expensing stock
options in accordance with FAS 123R, while the prior year quarter included
expenses of $103.0 million related to the multi-district settlement agreement.
Specialty: Operating gain totaled $138.1 million in the second quarter of
2006, an increase of 39.5 percent compared with $99.0 million in the second
quarter of 2005.
Second quarter 2006 operating gain increased by $39.2 million, or 39.6
percent, on a comparable basis, from $98.9 million in the prior year quarter.
The increase resulted primarily from favorable experience in the life and
disability lines of business. In addition, the Company continues to see
growth in its on-going specialty operations.
OUTLOOK
Full Year 2006:
- The Company now expects net income of $4.74 per share, including net
realized investment losses of $0.02 per share. This estimate assumes
the Company completes its remaining share repurchase authorization
during the third quarter of 2006.
- Operating revenue is expected to total approximately $56.4 billion.
- The benefit expense ratio is expected to be approximately 80.9 percent.
- The SG&A expense ratio is expected to be approximately 16.0 percent.
- Operating cash flow is expected to exceed $4.0 billion.
- Year-end medical enrollment is expected to be approximately 34.5
million members.
Third Quarter 2006:
-
The Company now expects net income of $1.22 per share in the third
quarter.
Basis of Presentation
1. Operating gain is defined as operating revenue less benefit expense,
selling expense, general and administrative expense, and cost of drugs.
Operating gain is used to analyze profit or loss on a segment basis.
Consolidated operating gain is a non-GAAP measure.
2. On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc.
Accordingly, operations of the former WellChoice, Inc. are included in
reported financial results for 2006. However, operations of the former
WellChoice, Inc. are not included in reported financial results for 2005.
3. Amounts for 2005 and prior do not include the impact of expensing
stock options in accordance with FAS 123R. The Company's 2006 reported
results and its outlook for the remainder of 2006, however, do include this
impact.
4. Certain prior period amounts have been reclassified to conform to
current period presentation.
Conference Call and Webcast
Management will host a conference call and webcast today at 8:30 a.m.
Eastern Daylight Time ("EDT") to discuss its second quarter earnings results
and updated outlook. The conference call should be accessed at least 15
minutes prior to the start of the call with the following numbers:
888-423-3268 (Domestic) 800-475-6701 (Domestic Replay)
651-291-5254 (International) 320-365-3844 (International Replay)
An access code is not required for today's conference call. The access
code for the replay is 831808. The replay will be available from 1:45 p.m.
EDT today until the end of the day on August 9, 2006. The call will also be
available through a live webcast at http://www.wellpoint.com under "Investor
Info." A webcast replay will be available following the call.
About WellPoint, Inc.
WellPoint's mission is to improve the lives of the people it serves and
the health of its communities. WellPoint, Inc. is the largest health benefits
company in terms of commercial membership in the United States. Through its
nationwide networks, the company delivers a number of leading health benefit
solutions through a broad portfolio of integrated health care plans and
related services, along with a wide range of specialty products such as life
and disability insurance benefits, pharmacy benefit management, dental,
vision, behavioral health benefit services, as well as long term care
insurance and flexible spending accounts. Headquartered in Indianapolis,
Indiana, WellPoint is an independent licensee of the Blue Cross and Blue
Shield Association and serves its members as the Blue Cross licensee for
California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut,
Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the
Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield
in 10 New York City metropolitan and surrounding counties and as Blue Cross or
Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia
(excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and
through UniCare. Additional information about WellPoint is available at
http://www.wellpoint.com .
WellPoint, Inc.
Medical Membership & Specialty Metrics Summary
(Unaudited and in Thousands)
Medical Membership
As Reported
June 30, June 30,
2006 2005
Customer Type
Large Group 15,959 13,220
Individual and Small Group ("ISG") 5,651 5,276
National Accounts 5,142 3,478
BlueCard 4,194 4,000
Total National 9,336 7,478
Senior 1,246 1,065
State Sponsored 1,971 1,804
Total 34,163 28,843
Funding Arrangement
Self-Funded 16,980 14,420
Fully-Insured 17,183 14,423
Total 34,163 28,843
Regional Membership
East 13,779 8,723
Central 11,051 10,997
West 9,333 9,123
Total 34,163 28,843
Specialty Metrics
PBM Prescription Volume (2) 96,919 84,437
Behavioral Health Membership 15,938 12,528
Life and Disability Membership 5,964 5,797
Dental Membership 5,258 5,271
Medicare Part D Membership (3) 1,527 -
Vision Membership 940 789
Comparable
Basis (1)
June 30, December 31,
2005 2005
Customer Type
Large Group 16,242 16,362
Individual and Small Group ("ISG") 5,611 5,645
National Accounts 4,716 4,776
BlueCard 3,894 3,915
Total National 8,610 8,691
Senior 1,215 1,224
State Sponsored 1,869 1,934
Total 33,547 33,856
Funding Arrangement
Self-Funded 16,238 16,584
Fully-Insured 17,309 17,272
Total 33,547 33,856
Regional Membership
East 13,672 13,800
Central 10,871 10,970
West 9,004 9,086
Total 33,547 33,856
Specialty Metrics
PBM Prescription Volume (2) 84,437 91,813
Behavioral Health Membership 12,528 15,669
Life and Disability Membership 5,797 5,826
Dental Membership 5,534 5,195
Medicare Part D Membership (3) - -
Vision Membership 789 816
Change from
Comparable
Basis (1)
June 30, December 31,
2005 2005
Customer Type
Large Group (1.7%) (2.5%)
Individual and Small Group ("ISG") 0.7% 0.1%
National Accounts 9.0% 7.7%
BlueCard 7.7% 7.1%
Total National 8.4% 7.4%
Senior 2.6% 1.8%
State Sponsored 5.5% 1.9%
Total 1.8% 0.9%
Funding Arrangement
Self-Funded 4.6% 2.4%
Fully-Insured (0.7%) (0.5%)
Total 1.8% 0.9%
Regional Membership
East 0.8% (0.2%)
Central 1.7% 0.7%
West 3.7% 2.7%
Total 1.8% 0.9%
Specialty Metrics
PBM Prescription Volume (2) 14.8% 5.6%
Behavioral Health Membership 27.2% 1.7%
Life and Disability Membership 2.9% 2.4%
Dental Membership (5.0%) 1.2%
Medicare Part D Membership (3) - -
Vision Membership 19.1% 15.2%
(1) "Comparable Basis" data was calculated by adding historical data for
the former WellChoice, Inc. to WellPoint, Inc.'s historical data, and
adjusting the combined totals to ensure a consistent approach for counting
membership and to eliminate overlapping BlueCard host membership.
(2) Represents quarterly prescription volume at the Company's PBM
operation.
(3) Includes auto-assigned, stand-alone, Medicare Advantage, group waiver
and external PBM members with the prescription drug plan benefit.
WellPoint, Inc.
Consolidated Statements of Income
(Unaudited)
($ In Millions, Except Per Share Data) Three Months Ended
June 30
2006 2005 Change
Revenues
Premiums $12,918.8 $10,196.8 26.7%
Administrative fees 877.1 664.2 32.1%
Other revenue 146.4 125.4 16.7%
Total operating revenue 13,942.3 10,986.4 26.9%
Net investment income 218.5 159.8 36.7%
Net realized (losses) gains on
investments (8.9) 2.8 -
Total revenues 14,151.9 11,149.0 26.9%
Expenses
Benefit expense 10,492.3 8,229.6 27.5%
Selling, general and administrative
expense
Selling expense 413.2 367.6 12.4%
General and administrative
expense 1,778.9 1,465.3 21.4%
Total selling, general and
administrative expense 2,192.1 1,832.9 19.6%
Cost of drugs 85.8 71.1 20.7%
Interest expense 103.9 58.9 76.4%
Amortization of other intangible
assets 74.5 59.9 24.4%
Total expenses 12,948.6 10,252.4 26.3%
Income before income taxes 1,203.3 896.6 34.2%
Income taxes 452.1 337.2 34.1%
Net income $751.2 $559.4 34.3%
Net income per diluted share $1.17 $0.90 30.0%
Diluted shares (in millions) 642.0 624.8 2.8%
Benefit expense as a percentage of
premiums 81.2% 80.7% 50 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 15.7% 16.7% (100)bp
Income before income taxes as a
percentage of total revenues 8.5% 8.0% 50 bp
WellPoint, Inc.
Consolidated Statements of Income
(Unaudited)
($ In Millions, Except Per Share Data) Six Months Ended
June 30
2006 2005 Change
Revenues
Premiums $25,497.7 $20,212.7 26.1%
Administrative fees 1,761.1 1,324.9 32.9%
Other revenue 298.2 254.2 17.3%
Total operating revenue 27,557.0 21,791.8 26.5%
Net investment income 430.6 298.5 44.3%
Net realized (losses) gains on
investments (16.0) 1.8 -
Total revenues 27,971.6 22,092.1 26.6%
Expenses
Benefit expense 20,723.1 16,328.7 26.9%
Selling, general and administrative
expense
Selling expense 814.6 727.1 12.0%
General and administrative
expense 3,550.1 2,834.9 25.2%
Total selling, general and
administrative expense 4,364.7 3,562.0 22.5%
Cost of drugs 161.6 144.7 11.7%
Interest expense 197.9 112.1 76.5%
Amortization of other intangible
assets 148.3 119.1 24.5%
Total expenses 25,595.6 20,266.6 26.3%
Income before income taxes 2,376.0 1,825.5 30.2%
Income taxes 893.0 654.4 36.5%
Net income $1,483.0 $1,171.1 26.6%
Net income per diluted share $2.26 $1.88 20.2%
Diluted shares (in millions) 655.5 623.2 5.2%
Benefit expense as a percentage of
premiums 81.3% 80.8% 50 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 15.8% 16.3% (50)bp
Income before income taxes as a
percentage of total revenues 8.5% 8.3% 20 bp
WellPoint, Inc.
Consolidated Balance Sheets
June 30, December 31,
($ In Millions) 2006 2005
(Unaudited)
Assets
Current assets:
Cash and cash equivalents $1,934.4 $2,740.2
Investments available-for-sale, at
fair value 1,982.2 2,182.8
Other invested assets, current 402.5 307.0
Accrued investment income 156.2 156.8
Premiums and self-funded
receivables 2,360.6 2,216.4
Other receivables 1,148.9 831.4
Securities lending collateral 703.7 1,389.9
Deferred tax assets, net 728.8 689.0
Other current assets 1,167.8 1,022.7
Total current assets 10,585.1 11,536.2
Long-term investments available-for-
sale, at fair value 14,843.9 14,898.2
Other invested assets, long-term 250.9 207.8
Property and equipment, net 1,014.9 1,078.6
Goodwill 13,449.2 13,469.1
Other intangible assets 9,538.1 9,686.4
Other noncurrent assets 409.7 410.9
Total assets $50,091.8 $51,287.2
Liabilities and shareholders' equity
Liabilities
Current liabilities:
Policy liabilities:
Medical claims payable $5,162.6 $4,853.4
Reserves for future policy
benefits 82.1 82.1
Other policyholder liabilities 1,928.5 1,752.3
Total policy liabilities 7,173.2 6,687.8
Unearned income 1,596.5 1,057.1
Accounts payable and accrued
expenses 2,656.4 2,860.4
Income taxes payable 729.9 833.4
Security trades pending payable 9.3 181.8
Securities lending payable 703.7 1,389.9
Current portion of long-term debt 22.4 481.2
Other current liabilities 1,451.3 1,286.8
Total current liabilities 14,342.7 14,778.4
Long-term debt, less current portion 7,446.4 6,324.7
Reserves for future policy benefits,
noncurrent 653.3 679.9
Deferred tax liability, net 3,083.5 3,267.1
Other noncurrent liabilities 1,328.1 1,244.0
Total liabilities 26,854.0 26,294.1
Shareholders' equity
Common stock 6.2 6.6
Additional paid-in capital 19,846.3 20,915.4
Retained earnings 3,581.5 4,173.5
Unearned stock compensation - (82.1)
Accumulated other comprehensive loss (196.2) (20.3)
Total shareholders' equity 23,237.8 24,993.1
Total liabilities and shareholders'
equity $50,091.8 $51,287.2
WellPoint, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
Six Months Ended June 30
($ In Millions) 2006 2005
Operating activities
Net income $1,483.0 $1,171.1
Adjustments to reconcile net income
to net cash provided by operating
activities:
Net realized losses (gains)
on investments 16.0 (1.8)
Loss on disposal of assets 0.9 0.2
Deferred income taxes (40.5) (45.0)
Amortization, net of
accretion 230.1 224.7
Depreciation 68.5 59.5
Share-based compensation 141.1 36.3
Excess tax benefits from
share-based compensation (62.4) -
Changes in operating assets
and liabilities, net of
effect of business
combinations:
Receivables, net (467.6) (78.8)
Other invested
assets, current (95.2) -
Other assets (142.3) (48.8)
Policy liabilities 468.8 95.7
Unearned income 539.4 6.0
Accounts payable and
accrued expenses (304.0) 135.6
Other liabilities 181.2 (253.0)
Income taxes (18.4) 289.6
Net cash provided by operating
activities 1,998.6 1,591.3
Investing activities
Purchases of investments (9,517.9) (10,011.3)
Proceeds from sales and maturities of
investments 9,255.5 9,382.4
Changes in securities lending
collateral 686.2 (77.3)
Purchases of subsidiaries, net of
cash acquired - (312.6)
Payment for settlement of cash flow
hedge (24.7) -
Purchases of property and equipment (72.8) (85.6)
Proceeds from sales of property and
equipment - 6.7
Net cash provided by (used in)
investing activities 326.3 (1,097.7)
Financing activities
Net proceeds from commercial paper
borrowings 191.5 202.4
Proceeds from long-term borrowings 2,668.9 -
Repayment of long-term borrowings (2,156.7) -
Changes in securities lending payable (686.2) 77.3
Changes in bank overdrafts 124.0 (226.7)
Repurchase and retirement of common
stock (3,600.4) (333.4)
Proceeds from exercise of employee
stock options and employee stock purchase
plan 265.8 281.8
Proceeds from sale of put options - 1.1
Excess tax benefits from share-based
compensation 62.4 -
Net cash (used in) provided by
financing activities (3,130.7) 2.5
Change in cash and cash equivalents (805.8) 496.1
Cash and cash equivalents at
beginning of period 2,740.2 1,457.2
Cash and cash equivalents at end of
period $1,934.4 $1,953.3
WellPoint, Inc.
Reconciliation of Medical Claims Payable
Six Months Ended
June 30
($ In Millions) 2006 2005
(Unaudited)
Gross medical claims payable, beginning of period $4,853.4 $4,134.0
Ceded medical claims payable, beginning of period (27.7) (31.9)
Net medical claims payable, beginning of period 4,825.7 4,102.1
Business combinations and purchase adjustments (6.4) -
Net incurred medical claims:
Current year 21,156.8 16,671.0
Prior years (redundancies) (1) (556.7) (571.0)
Total net incurred medical claims 20,600.1 16,100.0
Net payments attributable to:
Current year medical claims 16,534.4 12,934.0
Prior years medical claims 3,752.1 3,083.1
Total net payments 20,286.5 16,017.1
Net medical claims payable, end of period 5,132.9 4,185.0
Ceded medical claims, end of period 29.7 36.5
Gross medical claims payable, end of period $5,162.6 $4,221.5
Current year medical claims paid as a percent of
current year net incurred medical claims 78.2% 77.6%
Prior year redundancies in the current period as
a percent of prior year net medical claims
payables less prior year redundancies in the
current period 13.0% 16.2%
Prior year redundancies in the current period as
a percent of prior year net incurred medical
claims - as reported (3) 1.7% 3.7%
Prior year redundancies in the current period as
a percent of prior year net incurred medical
claims - adjusted for acquisitions (3) 1.5% 1.9%
Year Ended December 31
($ In Millions) 2005 2004 2003
Gross medical claims payable, beginning
of period $4,134.0 $1,836.0 $1,797.3
Ceded medical claims payable, beginning
of period (31.9) (8.7) (2.8)
Net medical claims payable, beginning of
period 4,102.1 1,827.3 1,794.5
Business combinations and purchase
adjustments 784.5 2,331.0 (20.6)
Net incurred medical claims:
Current year 32,865.6 15,344.9 12,316.7
Prior years (redundancies) (1) (644.9) (171.9) (225.9)
Total net incurred medical claims 32,220.7 15,173.0 12,090.8
Net payments attributable to:
Current year medical claims 28,997.1 12,453.2 10,546.5
Prior years medical claims 3,284.5 2,776.0 1,490.9
Total net payments 32,281.6 15,229.2 12,037.4
Net medical claims payable, end of period 4,825.7 4,102.1 1,827.3
Ceded medical claims, end of period 27.7 31.9 8.7
Gross medical claims payable, end of
period $4,853.4 $4,134.0 $1,836.0
Current year medical claims paid as a
percent of current year net incurred
medical claims 88.2% 81.2%(2) 85.6%
Prior year redundancies in the current
period as a percent of prior year net
medical claims payables less prior year
redundancies in the current period 18.7% 10.4% 14.4%
Prior year redundancies in the current
period as a percent of prior year net
incurred medical claims - as reported (3) 4.2% 1.4% 2.3%
Prior year redundancies in the current
period as a percent of prior year net
incurred medical claims - adjusted for
acquisitions (3) 2.1% 1.4% 2.0%
(1) Negative amounts reported for net incurred medical claims related to
prior years result from claims being settled for amounts less than originally
estimated.
(2) This ratio is impacted by having only one month of net incurred
medical claims and payments for the former WellPoint Health Networks Inc.
("WHN") in 2004. If WHN had not been included in 2004, current year medical
claims paid would have been $12,057.7 million, current year net incurred
medical claims would have been $13,835.1 million and the adjusted ratio would
have been 87.2%.
(3) For all periods presented, except for the year ended December 31,
2004, the reported ratio of prior year redundancies in the current period to
prior year net incurred medical claims is impacted by certain acquisitions
(the former WellChoice, Inc. in 2005, WHN in 2004 and the former Trigon
Healthcare, Inc. in 2002). The Company has provided ratios adjusted for these
acquisitions in order to demonstrate these impacts. Refer to the table
entitled, "Reconciliation of Medical Claims Payable - Adjusted Ratios" for
details regarding the respective calculation methodologies.
WellPoint, Inc.
Reconciliation of Medical Claims Payable - Adjusted Ratios
(Unaudited)
Note: Below are reconciliations for the adjusted ratios of prior year
redundancies in the current period to prior year net incurred medical claims
that are included in table entitled, "Reconciliation of Medical Claims
Payable."
Ratio for the Six Months Ended June 30, 2006
This ratio is impacted by having no net incurred medical claims for the
former WellChoice, Inc. ("WC") in 2005.
Net incurred medical claims related to prior years
(redundancies) - six months ended June 30, 2006
(As Reported) $556.7
Net incurred medical claims - year ended December 31,
2005 (As Reported) $32,865.6
Ratio (As Reported) 1.7%
Net incurred medical claims - year ended December 31,
2005 (Comparable Basis) (1) $37,676.0
Ratio (As Adjusted) 1.5%
(1) Represents comparable benefit expense, assuming WC had been
owned for the entire year ended December 31, 2005.
Ratio for the Six Months Ended June 30, 2005
This ratio is impacted by having only one month of net incurred medical
claims for the former WellPoint Health Networks Inc. ("WHN") in 2004.
Net incurred medical claims related to prior years
(redundancies) - six months ended June 30, 2005
(As Reported) $571.0
Net incurred medical claims - year ended December 31,
2004 (As Reported) $15,344.9
Ratio (As Reported) 3.7%
Net incurred medical claims - year ended December 31,
2004 (Comparable Basis) (2) $30,819.1
Ratio (As Adjusted) 1.9%
(2) Represents comparable benefit expense, assuming WHN had been
owned for the entire year ended December 31, 2004.
Ratio for the Year Ended December 31, 2005
This ratio is impacted by having only one month of net incurred medical
claims for WHN in 2004.
Net incurred medical claims related to prior years
(redundancies) - year ended December 31, 2005
(As Reported) $644.9
Net incurred medical claims - year ended December 31,
2004 (As Reported) $15,344.9
Ratio (As Reported) 4.2%
Net incurred medical claims - year ended December 31,
2004 (Comparable Basis) (3) $30,819.1
Ratio (As Adjusted) 2.1%
(3) Represents comparable benefit expense, assuming WHN had been
owned for the entire year ended December 31, 2004.
Ratio for the Year Ended December 31, 2003
This ratio is impacted by having only five months of net incurred medical
claims for the former Trigon Healthcare, Inc. ("TGH") in 2002.
Net incurred medical claims related to prior years
(redundancies) - year ended December 31, 2003
(As Reported) $225.9
Net incurred medical claims - year ended December 31,
2002 (As Reported) $9,838.5
Ratio (As Reported) 2.3%
Net incurred medical claims - year ended December 31,
2002 (Comparable Basis) (4) $11,057.8
Ratio (As Adjusted) 2.0%
(4) Represents comparable benefit expense, assuming TGH had been
owned for the entire year ended December 31, 2002.
WellPoint, Inc.
Selected Financial Data - Comparable Basis Analysis
(Unaudited)
($ In Millions) As Reported
Three Months Ended June 30
2006 2005 % Change
Revenues
Premiums $12,918.8 $10,196.8 26.7%
Administrative fees 877.1 664.2 32.1%
Other revenue 146.4 125.4 16.7%
Total operating revenue 13,942.3 10,986.4 26.9%
Expenses
Benefit expense 10,492.3 8,229.6 27.5%
Selling, general and administrative
expense
Selling expense 413.2 367.6 12.4%
General and administrative
expense 1,778.9 1,465.3 21.4%
Total selling, general and
administrative expense 2,192.1 1,832.9 19.6%
Cost of drugs 85.8 71.1 20.7%
Benefit expense as a percentage of
premiums 81.2% 80.7% 50 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 15.7% 16.7% (100)bp
($ In Millions) Comparable Basis (1)
Three Months Ended June 30
2005 $ Change % Change
Revenues
Premiums $11,683.4 $1,235.4 10.6%
Administrative fees 807.9 69.2 8.6%
Other revenue 125.3 21.1 16.8%
Total operating revenue 12,616.6 1,325.7 10.5%
Expenses
Benefit expense 9,497.1 995.2 10.5%
Selling, general and administrative
expense
Selling expense 386.6 26.6 6.9%
General and administrative
expense 1,713.3 65.6 3.8%
Total selling, general and
administrative expense 2,099.9 92.2 4.4%
Cost of drugs 71.1 14.7 20.7%
Benefit expense as a percentage of
premiums 81.3% (10)bp
Selling, general and administrative
expense as a percentage of total
operating revenue 16.6% (90)bp
($ In Millions) As Reported
Six Months Ended June 30
2006 2005 % Change
Revenues
Premiums $25,497.7 $20,212.7 26.1%
Administrative fees 1,761.1 1,324.9 32.9%
Other revenue 298.2 254.2 17.3%
Total operating revenue 27,557.0 21,791.8 26.5%
Expenses
Benefit expense 20,723.1 16,328.7 26.9%
Selling, general and administrative
expense
Selling expense 814.6 727.1 12.0%
General and administrative
expense 3,550.1 2,834.9 25.2%
Total selling, general and
administrative expense 4,364.7 3,562.0 22.5%
Cost of drugs 161.6 144.7 11.7%
Benefit expense as a percentage of
premiums 81.3% 80.8% 50 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 15.8% 16.3% (50)bp
($ In Millions) Comparable Basis (1)
Six Months Ended June 30
2005 $ Change % Change
Revenues
Premiums $23,064.8 $2,432.9 10.5%
Administrative fees 1,628.5 132.6 8.1%
Other revenue 254.0 44.2 17.4%
Total operating revenue 24,947.3 2,609.7 10.5%
Expenses
Benefit expense 18,777.1 1,946.0 10.4%
Selling, general and administrative
expense
Selling expense 763.3 51.3 6.7%
General and administrative
expense 3,314.2 235.9 7.1%
Total selling, general and
administrative expense 4,077.5 287.2 7.0%
Cost of drugs 144.7 16.9 11.7%
Benefit expense as a percentage of
premiums 81.4% (10)bp
Selling, general and administrative
expense as a percentage of total
operating revenue 16.3% (50)bp
(1) The "Comparable Basis" information is a non-GAAP measure. Refer to
the tables entitled, "Reclassified Consolidated Statements of Income -
Comparable Basis Reconciliation."
WellPoint, Inc.
Reportable Segment Highlights - Comparable Basis Analysis
(Unaudited)
($ In Millions) As Reported
Three Months Ended June 30
2006 2005 % Change
Operating Revenue
Health Care Segment $13,391.2 $10,474.9 27.8%
Specialty Segment 880.4 752.6 17.0%
Other Segment (329.3) (241.1) (36.6%)
Total Operating Revenue 13,942.3 10,986.4 26.9%
Operating Gain (Loss)
Health Care Segment $1,060.6 $777.2 36.5%
Specialty Segment 138.1 99.0 39.5%
Other Segment (26.6) (23.4) (13.7%)
Operating Margin (2)
Health Care Segment 7.9% 7.4% 50 bp
Specialty Segment 15.7% 13.2% 250 bp
($ In Millions) Comparable Basis (1)
Three Months Ended June 30
2005 $ Change % Change
Operating Revenue
Health Care Segment $12,064.2 $1,327.0 11.0%
Specialty Segment 760.3 120.1 15.8%
Other Segment (207.9) (121.4) (58.4%)
Total Operating Revenue 12,616.6 1,325.7 10.5%
Operating Gain (Loss)
Health Care Segment $874.9 $185.7 21.2%
Specialty Segment 98.9 39.2 39.6%
Other Segment (25.3) (1.3) (5.1%)
Operating Margin (2)
Health Care Segment 7.3% 60 bp
Specialty Segment 13.0% 270 bp
($ In Millions) As Reported
Six Months Ended June 30
2006 2005 % Change
Operating Revenue
Health Care Segment $26,449.1 $20,758.0 27.4%
Specialty Segment 1,734.6 1,503.5 15.4%
Other Segment (626.7) (469.7) (33.4%)
Total Operating Revenue 27,557.0 21,791.8 26.5%
Operating Gain (Loss)
Health Care Segment $2,096.5 $1,633.9 28.3%
Specialty Segment 251.7 193.4 30.1%
Other Segment (40.6) (70.9) 42.7%
Operating Margin (2)
Health Care Segment 7.9% 7.9% 0 bp
Specialty Segment 14.5% 12.9% 160 bp
($ In Millions) Comparable Basis (1)
Six Months Ended June 30
2005 $ Change % Change
Operating Revenue
Health Care Segment $23,830.3 $2,618.8 11.0%
Specialty Segment 1,519.5 215.1 14.2%
Other Segment (402.5) (224.2) (55.7%)
Total Operating Revenue 24,947.3 2,609.7 10.5%
Operating Gain (Loss)
Health Care Segment $1,828.6 $267.9 14.7%
Specialty Segment 193.9 57.8 29.8%
Other Segment (74.5) 33.9 45.5%
Operating Margin (2)
Health Care Segment 7.7% 20 bp
Specialty Segment 12.8% 170 bp
(1) The "Comparable Basis" information is a non-GAAP measure. Refer to
the tables entitled, "Reclassified Reportable Segment Highlights - Comparable
Basis Reconciliation."
(2) Operating margin is calculated as operating gain as a percentage of
operating revenue.
WellPoint, Inc.
Reclassified Consolidated Statements of Income - Comparable Basis
Reconciliation
(Unaudited)
Three Months Ended June 30, 2005
($ In Millions) WLP (1) WLP (1)
As Reported Reclassifications (2) Reclassified
Revenues
Premiums $10,332.9 $(136.1) $10,196.8
Administrative fees 667.8 (3.6) 664.2
Other revenue (expense) 135.9 (10.5) 125.4
Total operating revenue 11,136.6 (150.2) 10,986.4
Net investment income 159.8 - 159.8
Net realized gains on
investments 2.8 - 2.8
Total revenues 11,299.2 (150.2) 11,149.0
Expenses
Benefit expense 8,379.8 (150.2) 8,229.6
Selling, general and
administrative expense
Selling expense 367.6 - 367.6
General and administrative
expense 1,465.3 - 1,465.3
Total selling, general
and administrative
expense 1,832.9 - 1,832.9
Cost of drugs 71.1 - 71.1
Interest expense 58.9 - 58.9
Amortization of other
intangible assets 59.9 - 59.9
Total expenses 10,402.6 (150.2) 10,252.4
Income before income taxes 896.6 - 896.6
Income taxes 337.2 - 337.2
Net income $559.4 $- $559.4
Benefit expense as a
percentage of premiums 81.1% 80.7%
Selling, general and
administrative expense as a
percentage of total operating
revenue 16.5% 16.7%
Three Months Ended June 30, 2005
($ In Millions) WC (1)
As Reported Reclassifications (2)
Revenues
Premiums $1,491.1 $(4.5)
Administrative fees 139.8 3.9
Other revenue (expense) (0.1) -
Total operating revenue 1,630.8 (0.6)
Net investment income 20.1 -
Net realized gains on investments 3.0 -
Total revenues 1,653.9 (0.6)
Expenses
Benefit expense 1,283.2 (15.7)
Selling, general and administrative
expense
Selling expense - 19.0
General and administrative
expense 251.9 (3.9)
Total selling, general and
administrative expense 251.9 15.1
Cost of drugs - -
Interest expense - -
Amortization of other intangible
assets - -
Total expenses 1,535.1 (0.6)
Income before income taxes 118.8 -
Income taxes 44.2 -
Net income $74.6 $-
Benefit expense as a percentage of
premiums 86.1%
Selling, general and administrative
expense as a
percentage of total operating
revenue 15.4%
Three Months Ended June 30, 2005
($ In Millions) WC (1) WellPoint, Inc.
Reclassified Comparable Basis (3)
Revenues
Premiums $1,486.6 $11,683.4
Administrative fees 143.7 807.9
Other revenue (expense) (0.1) 125.3
Total operating revenue 1,630.2 12,616.6
Net investment income 20.1 179.9
Net realized gains on investments 3.0 5.8
Total revenues 1,653.3 12,802.3
Expenses
Benefit expense 1,267.5 9,497.1
Selling, general and administrative
expense
Selling expense 19.0 386.6
General and administrative expense 248.0 1,713.3
Total selling, general and
administrative expense 267.0 2,099.9
Cost of drugs - 71.1
Interest expense - 58.9
Amortization of other intangible
assets - 59.9
Total expenses 1,534.5 11,786.9
Income before income taxes 118.8 1,015.4
Income taxes 44.2 381.4
Net income $74.6 $634.0
Benefit expense as a percentage of
premiums 85.3% 81.3%
Selling, general and administrative
expense as a percentage of total
operating revenue 16.4% 16.6%
(1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.
(2) To reflect the reclassification of certain historical amounts to a
consistent presentation format adopted by the combined organization. In
connection with the acquisition of WellChoice, Inc., the Company adopted a
consistent practice for reporting minimum premium amendments to fully-insured
contracts throughout the combined enterprise.
(3) The "Comparable Basis" information was calculated by adding the
reclassified consolidated statements of income for WellPoint, Inc. and the
former WellChoice, Inc.
This "Comparable Basis" information contains no intercompany eliminations
or pro forma adjustments resulting from WellPoint, Inc.'s acquisition of
WellChoice, Inc.
"Comparable Basis" information is presented in order to provide investors
with a more meaningful comparison to the current period, due to the
acquisition of WellChoice, Inc.
"Comparable Basis" information is not calculated in accordance with GAAP
and is not intended to represent or be indicative of the results that
WellPoint, Inc. would have reported, had the acquisition been completed as of
January 1, 2005.
WellPoint, Inc.
Reclassified Consolidated Statements of Income - Comparable Basis
Reconciliation
(Unaudited)
Six Months Ended June 30, 2005
($ In Millions) WLP (1) WLP (1)
As Reported Reclassifications (2) Reclassified
Revenues
Premiums $20,491.7 $(279.0) $20,212.7
Administrative fees 1,332.0 (7.1) 1,324.9
Other revenue (expense) 275.1 (20.9) 254.2
Total operating revenue 22,098.8 (307.0) 21,791.8
Net investment income 298.5 - 298.5
Net realized gains on
investments 1.8 - 1.8
Total revenues 22,399.1 (307.0) 22,092.1
Expenses
Benefit expense 16,635.7 (307.0) 16,328.7
Selling, general and
administrative expense
Selling expense 727.1 - 727.1
General and administrative
expense 2,834.9 - 2,834.9
Total selling, general
and administrative
expense 3,562.0 - 3,562.0
Cost of drugs 144.7 - 144.7
Interest expense 112.1 - 112.1
Amortization of other
intangible assets 119.1 - 119.1
Total expenses 20,573.6 (307.0) 20,266.6
Income before income taxes 1,825.5 - 1,825.5
Income taxes 654.4 - 654.4
Net income $1,171.1 $- $1,171.1
Benefit expense as a
percentage of premiums 81.2% 80.8%
Selling, general and
administrative expense as a
percentage of total operating
revenue 16.1% 16.3%
Six Months Ended June 30, 2005
($ In Millions) WC (1)
As Reported Reclassifications (2)
Revenues
Premiums $2,876.2 $(24.1)
Administrative fees 281.1 22.5
Other revenue (expense) (0.2) -
Total operating revenue 3,157.1 (1.6)
Net investment income 37.9 -
Net realized gains on investments 3.6 -
Total revenues 3,198.6 (1.6)
Expenses
Benefit expense 2,480.5 (32.1)
Selling, general and administrative
expense
Selling expense - 36.2
General and administrative
expense 485.0 (5.7)
Total selling, general and
administrative expense 485.0 30.5
Cost of drugs - -
Interest expense - -
Amortization of other intangible
assets - -
Total expenses 2,965.5 (1.6)
Income before income taxes 233.1 -
Income taxes 87.6 -
Net income $145.5 $-
Benefit expense as a percentage of
premiums 86.2%
Selling, general and administrative
expense as a percentage of total
operating revenue 15.4%
Six Months Ended June 30, 2005
($ In Millions) WC (1) WellPoint, Inc.
Reclassified Comparable Basis (3)
Revenues
Premiums $2,852.1 $23,064.8
Administrative fees 303.6 1,628.5
Other revenue (expense) (0.2) 254.0
Total operating revenue 3,155.5 24,947.3
Net investment income 37.9 336.4
Net realized gains on investments 3.6 5.4
Total revenues 3,197.0 25,289.1
Expenses
Benefit expense 2,448.4 18,777.1
Selling, general and administrative
expense
Selling expense 36.2 763.3
General and administrative expense 479.3 3,314.2
Total selling, general and
administrative expense 515.5 4,077.5
Cost of drugs - 144.7
Interest expense - 112.1
Amortization of other intangible
assets - 119.1
Total expenses 2,963.9 23,230.5
Income before income taxes 233.1 2,058.6
Income taxes 87.6 742.0
Net income $145.5 $1,316.6
Benefit expense as a percentage of
premiums 85.8% 81.4%
Selling, general and administrative
expense as a percentage of total
operating revenue 16.3% 16.3%
(1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.
(2) To reflect the reclassification of certain historical amounts to a
consistent presentation format adopted by the combined organization. In
connection with the acquisition of WellChoice, Inc., the Company adopted a
consistent practice for reporting minimum premium amendments to fully-insured
contracts throughout the combined enterprise.
(3) The "Comparable Basis" information was calculated by adding the
reclassified consolidated statements of income for WellPoint, Inc. and the
former WellChoice, Inc.
This "Comparable Basis" information contains no intercompany eliminations
or pro forma adjustments resulting from WellPoint, Inc.'s acquisition of
WellChoice, Inc.
"Comparable Basis" information is presented in order to provide investors
with a more meaningful comparison to the current period, due to the
acquisition of WellChoice, Inc.
"Comparable Basis" information is not calculated in accordance with GAAP
and is not intended to represent or be indicative of the results that
WellPoint, Inc. would have reported, had the acquisition been completed as of
January 1, 2005.
WellPoint, Inc.
Reclassified Reportable Segment Highlights - Comparable Basis
Reconciliation
(Unaudited)
Three Months Ended June 30, 2005
($ In Millions) WLP (1) WLP (1)
As Reported Reclassifications (2) Reclassified
Operating Revenue (4)
Health Care $10,663.8 $(188.9) $10,474.9
Specialty 695.9 56.7 752.6
Other (223.1) (18.0) (241.1)
Commercial Managed Care - - -
Other Insurance Products and
Services - - -
Total operating revenue 11,136.6 (150.2) 10,986.4
Operating Gain (Loss) (4)
Health Care 785.6 (8.4) 777.2
Specialty 92.1 6.9 99.0
Other (24.9) 1.5 (23.4)
Commercial Managed Care - - -
Other Insurance Products and
Services - - -
Three Months Ended June 30, 2005
($ In Millions) WC (1)
As Reported Reclassifications (2)
Operating Revenue (4)
Health Care $- $1,589.3
Specialty - 7.7
Other - 33.2
Commercial Managed Care 1,402.7 (1,402.7)
Other Insurance Products and Services 228.1 (228.1)
Total operating revenue 1,630.8 (0.6)
Operating Gain (Loss) (4)
Health Care - 97.7
Specialty - (0.1)
Other - (1.9)
Commercial Managed Care 60.4 (60.4)
Other Insurance Products and Services 35.3 (35.3)
Three Months Ended June 30, 2005
($ In Millions) WC (1) WellPoint, Inc.
Reclassified Comparable Basis (3)
Operating Revenue (4)
Health Care $1,589.3 $12,064.2
Specialty 7.7 760.3
Other 33.2 (207.9)
Commercial Managed Care - -
Other Insurance Products and Services - -
Total operating revenue 1,630.2 12,616.6
Operating Gain (Loss) (4)
Health Care 97.7 874.9
Specialty (0.1) 98.9
Other (1.9) (25.3)
Commercial Managed Care - -
Other Insurance Products and Services - -
Six Months Ended June 30, 2005
($ In Millions) WLP (1) WLP (1)
As Reported Reclassifications (2) Reclassified
Operating Revenue (4)
Health Care $21,140.2 $(382.2) $20,758.0
Specialty 1,391.3 112.2 1,503.5
Other (432.7) (37.0) (469.7)
Commercial Managed Care - - -
Other Insurance Products and
Services - - -
Total operating revenue 22,098.8 (307.0) 21,791.8
Operating Gain (Loss) (4)
Health Care 1,646.2 (12.3) 1,633.9
Specialty 183.8 9.6 193.4
Other (73.6) 2.7 (70.9)
Commercial Managed Care - - -
Other Insurance Products and
Services - - -
Six Months Ended June 30, 2005
($ In Millions) WC (1)
As Reported Reclassifications (2)
Operating Revenue (4)
Health Care $- $3,072.3
Specialty - 16.0
Other - 67.2
Commercial Managed Care 2,702.5 (2,702.5)
Other Insurance Products and Services 454.6 (454.6)
Total operating revenue 3,157.1 (1.6)
Operating Gain (Loss) (4)
Health Care - 194.7
Specialty - 0.5
Other - (3.6)
Commercial Managed Care 146.0 (146.0)
Other Insurance Products and Services 45.6 (45.6)
Six Months Ended June 30, 2005
($ In Millions) WC (1) WellPoint, Inc.
Reclassified Comparable Basis (3)
Operating Revenue (4)
Health Care $3,072.3 $23,830.3
Specialty 16.0 1,519.5
Other 67.2 (402.5)
Commercial Managed Care - -
Other Insurance Products and Services - -
Total operating revenue 3,155.5 24,947.3
Operating Gain (Loss) (4)
Health Care 194.7 1,828.6
Specialty 0.5 193.9
Other (3.6) (74.5)
Commercial Managed Care - -
Other Insurance Products and Services - -
(1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.
(2) To reflect the reclassification of certain historical amounts to a
consistent presentation format adopted by the combined organization. In
connection with the acquisition of WellChoice, Inc., the Company adopted a
consistent practice for reporting minimum premium amendments to fully-insured
contracts throughout the combined enterprise.
(3) The "Comparable Basis" information was calculated by adding the
reclassified consolidated statements of income for WellPoint, Inc. and the
former WellChoice, Inc.
This "Comparable Basis" information contains no intercompany eliminations
or pro forma adjustments resulting from WellPoint, Inc.'s acquisition of
WellChoice, Inc.
"Comparable Basis" information is presented in order to provide investors
with a more meaningful comparison to the current period, due to the
acquisition of WellChoice, Inc.
"Comparable Basis" information is not calculated in accordance with GAAP
and is not intended to represent or be indicative of the results that
WellPoint, Inc. would have reported, had the acquisition been completed as of
January 1, 2005.
(4) Operating revenue and operating gain are the key measures used by
management to evaluate performance in each segment. Operating gain is defined
as operating revenue less benefit expense, selling expense, general and
administrative expense, and cost of drugs. Operating gain is used to analyze
profit or loss on a segment basis.
Consolidated operating gain is a non-GAAP measure.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES
LITIGATION REFORM ACT OF 1995
This press release contains certain forward-looking information about
WellPoint, Inc. ("WellPoint") that is intended to be covered by the safe
harbor for "forward-looking statements" provided by the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are statements that
are not historical facts. Words such as "expect(s)", "feel(s)", "believe(s)",
"will", "may", "anticipate(s)" and similar expressions are intended to
identify forward-looking statements. These statements include, but are not
limited to, financial projections and estimates and their underlying
assumptions; statements regarding plans, objectives and expectations with
respect to future operations, products and services; and statements regarding
future performance. Such statements are subject to certain risks and
uncertainties, many of which are difficult to predict and generally beyond the
control of WellPoint, that could cause actual results to differ materially
from those expressed in, or implied or projected by, the forward-looking
information and statements. These risks and uncertainties include: those
discussed and identified in public filings with the U.S. Securities and
Exchange Commission ("SEC") made by WellPoint and WellChoice, Inc.
("WellChoice"); trends in health care costs and utilization rates; our ability
to secure sufficient premium rate increases; competitor pricing below market
trends of increasing costs; increased government regulation of health benefits
and managed care; significant acquisitions or divestitures by major
competitors; introduction and utilization of new prescription drugs and
technology; a downgrade in our financial strength ratings; litigation and
investigations targeted at health benefits companies and our ability to
resolve litigation and investigations within estimates; our ability to
contract with providers consistent with past practice; other potential uses of
cash in the future that present attractive alternatives to share repurchases;
our ability to achieve expected synergies and operating efficiencies in the
WellPoint Health Networks Inc. merger and WellChoice acquisition within the
expected time-frames or at all and to successfully integrate our operations;
such integration may be more difficult, time-consuming or costly than
expected; revenues following the transactions may be lower than expected;
operating costs, customer loss and business disruption, including, without
limitation, difficulties in maintaining relationships with employees,
customers, clients or suppliers, may be greater than expected following the
transactions; our ability to meet expectations regarding repurchases of shares
of our common stock; our ability to meet expectations regarding the accounting
and tax treatments of the transactions and the value of transaction
consideration; future bio-terrorist activity or other potential public health
epidemics; and general economic downturns. Readers are cautioned not to place
undue reliance on these forward-looking statements that speak only as of the
date hereof. WellPoint does not undertake any obligation to republish revised
forward-looking statements to reflect events or circumstances after the date
hereof or to reflect the occurrence of unanticipated events. Readers are also
urged to carefully review and consider the various disclosures in WellPoint's
and WellChoice's various SEC reports, including but not limited to WellPoint's
Annual Report on Form 10-K for the year ended December 31, 2005, and its
Quarterly Reports on Form 10-Q for the reporting periods of 2006.
SOURCE WellPoint, Inc.
Investor Relations: Wayne DeVeydt, +1-317-488-6390, or Media: James Kappel,
+1-317-488-6400, both of WellPoint, Inc.